• Explore /
  • Poster
  • / The utility of genomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: The PREDICT IR study.

The utility of genomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: The PREDICT IR study.

Abstract Poster

Authors

null

Michael Michael

Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia

Michael Michael , Winston Liauw , Sue-Anne McLACHLAN , Emma Link , Anetta Matera , Mick Thompson , Michael Jefford , Rodney J Hicks , Carleen Cullinane , Ian Campbell , Philip James Beale , Christos Stelios Karapetis , Timothy Price , Matthew E. Burge

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Pharmacology

Clinical Trial Registration Number

ACTRN12610000898055

Citation

J Clin Oncol 35, 2017 (suppl; abstr 2564)

DOI

10.1200/JCO.2017.35.15_suppl.2564

Abstract #

2564

Poster Bd #

56

Abstract Disclosures

Similar Posters

First Author: Scott Kopetz

Poster

2018 ASCO Annual Meeting

The utility of genomics and functional imaging to predict Sunitinib PK and PD: The Predict SU study.

The utility of genomics and functional imaging to predict Sunitinib PK and PD: The Predict SU study.

First Author: Michael Michael

First Author: Li-Tzong Chen

First Author: Kentaro Yamazaki